Amicogen Financials
| 092040 Stock | KRW 3,650 25.00 0.69% |
Amicogen |
Understanding current and past Amicogen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amicogen's financial statements are interrelated, with each one affecting the others. For example, an increase in Amicogen's assets may result in an increase in income on the income statement.
Please note, the presentation of Amicogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amicogen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amicogen's management manipulating its earnings.
Amicogen Stock Summary
Amicogen competes with ALTEOGEN, Com2uS, and Paradise. Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company was founded in 2000 and is headquartered in Jinju, South Korea. Amicogen is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7092040005 |
| Business Address | 64, Dongbu-ro, Jinju-Si, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.amicogen.com |
| Phone | 82 5 5759 6161 |
| Currency | KRW - South Korean Won |
You should never invest in Amicogen without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amicogen Stock, because this is throwing your money away. Analyzing the key information contained in Amicogen's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amicogen Key Financial Ratios
Amicogen's financial ratios allow both analysts and investors to convert raw data from Amicogen's financial statements into concise, actionable information that can be used to evaluate the performance of Amicogen over time and compare it to other companies across industries.| Return On Equity | -21.03 | |||
| Return On Asset | 0.009 | |||
| Target Price | 100000.0 | |||
| Number Of Employees | 208 | |||
| Beta | 1.23 |
Amicogen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amicogen's current stock value. Our valuation model uses many indicators to compare Amicogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amicogen competition to find correlations between indicators driving Amicogen's intrinsic value. More Info.Amicogen is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amicogen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amicogen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Amicogen Systematic Risk
Amicogen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amicogen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Amicogen correlated with the market. If Beta is less than 0 Amicogen generally moves in the opposite direction as compared to the market. If Amicogen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amicogen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amicogen is generally in the same direction as the market. If Beta > 1 Amicogen moves generally in the same direction as, but more than the movement of the benchmark.
Amicogen March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amicogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amicogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amicogen based on widely used predictive technical indicators. In general, we focus on analyzing Amicogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amicogen's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.41 | |||
| Information Ratio | 0.0412 | |||
| Maximum Drawdown | 22.68 | |||
| Value At Risk | (7.24) | |||
| Potential Upside | 10.41 |
Complementary Tools for Amicogen Stock analysis
When running Amicogen's price analysis, check to measure Amicogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicogen is operating at the current time. Most of Amicogen's value examination focuses on studying past and present price action to predict the probability of Amicogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicogen's price. Additionally, you may evaluate how the addition of Amicogen to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |